Author

Gracjan Podgorski

Observed names: G Podgorski, G Podgórski, G. Podgorski, Gracjan Piotr Podgorski

Observed institution: Royal Perth Hospital

OpenAlex ID: A5018686140

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

2022 · Peter Rossing, Stefan D. Anker, et al. · Diabetes Care · 217

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

2016 · Sean D. Pokorney, Jonathan P. Piccini, et al. · Journal of the American Heart Association · 201

PDF

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

2023 · Rajiv Agarwal, Wanzhu Tu, et al. · Annals of Internal Medicine · 107

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

2022 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 38

Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel

2020 · Sanjay Kalra, Shehla Shaikh, et al. · Diabetes Therapy · 32

PDF

Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia

2021 · Ronald M. Goldenberg, Vanita R. Aroda, et al. · Diabetes Obesity and Metabolism · 29

PDF

Effect of Insulin Degludec U100 vs Insulin Glargine U100 on Time in Range in Patients with Type 2 Diabetes at Risk of Hypoglycaemia

2021 · R Goldenberg, VR Aroda, et al. · Diabetologie und Stoffwechsel · 4

Correction to: Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel

2021 · Sanjay Kalra, Shehla Shaikh, et al. · Diabetes Therapy · 2

PDF

[Comparison of the effectiveness of conventional and intensive insulin therapy in the treatment of diabetes mellitus type 1 in pregnant women or those planning pregnancy].

1987 · G Podgórski, J Tatoń, et al. · PubMed · 1

Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897

2023 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care

PDF

Initiating or switching to IDegAsp in a real-world South African population with type 2 diabetes – a cohort analysis from the ARISE study

2023 · Adri Kok, Hemant Makan, et al. · Journal of Endocrinology Metabolism and Diabetes of South Africa

PDF

Author response for "Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia"

2021 · Ronald M. Goldenberg, Vanita R. Aroda, et al.

488 a 6 Month Study Evaluating the Compliance of Patients Treated With a Fixed Dose Combination Anti-hypertensive Therapy, Exforge (amlodipine/valsartan) in South Africa. (the Exceed South African Survey)

2012 · Gracjan Podgorski, Adriaan Vermooten, et al. · Journal of Hypertension

[Microalbuminuria and early diagnosis of diabetic nephropathy].

1993 · G Podgórski, J Kołaczyński · PubMed

[Autoimmune polyendocrinopathy in insulin-dependent diabetes mellitus].

1987 · G Podgórski, J Tatoń, et al. · PubMed

[Fructosamine levels as an indicator of the glycosylation of serum proteins in diabetes mellitus type 1: clinical significance].

1987 · G Podgórski, A Czech, et al. · PubMed

[Patient education in the treatment of diabetes mellitus].

1984 · G Podgórski, J Tatoń, et al. · PubMed

[Prostaglandins, islands of Langerhans and glucose homeostasis].

1984 · J Tatoń, A Czech, et al. · PubMed

[Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].

1984 · J Tatoń, A Czech, et al. · PubMed

Works count: 20

Citation count: 631

H-index: 6

I10-index: 6